Phargomed El Salvador
WhatsApp
(11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)

Strem Chemicals

(11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee)

N° de parte: 15-1381

Ligands | Catalysts | Other Reagents

Cotizar por WhatsApp
El (11bR)-4-Hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 98%, (99% ee) de Strem Chemicals, con código SKU 15-1381, es un reactivo especializado en la categoría de ligandos y catalizadores. Este compuesto se utiliza en diversas aplicaciones químicas, especialmente en la investigación y desarrollo en laboratorios, universidades y clínicas en El Salvador. Su alta pureza y especificidad lo hacen ideal para usuarios que buscan resultados consistentes en sus experimentos y procesos de síntesis. Además, beneficia a instituciones como hospitales y laboratorios que requieren reactivos de calidad para sus análisis y estudios. Phargomed El Salvador es el distribuidor autorizado de la marca Strem Chemicals, ofreciendo entrega en todo el país y soporte local. Para más información y solicitudes de cotización en dólares, se invita a los interesados a contactarnos a través de WhatsApp.

Productos relacionados

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%

(11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-tricyclohexylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%

(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis[3,5-bis(tert-butyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 98%, (99% ee)

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)

(11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 95%, (99% ee)